To this end, we evaluated whether MLPA, a quantitative molecular method [26, 28, 29, 40] may be a helpful reflex test to define the HER2 status in 54 BC presenting a non classical HER2 ISH results (4.0–5.9 HER2 gene s/n). The gene discussed is ERBB2; the disease is breast cancer.